Clinical management of Clostridium difficile -: Associated disease

被引：34
|
作者：
Miller, Mark A. [1 ]
机构：
[1] McGill Univ, Jewish Gen Hosp, Infect Prevent & Control, Div Infect Dis & Clin Microbiol, Montreal, PQ H3T 1E2, Canada
来源：
CLINICAL INFECTIOUS DISEASES | 2007年 / 45卷
关键词：
D O I：
10.1086/519257
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The incidence of Clostridium difficile-associated disease (CDAD) and its serious complications ( including colectomy and death) have been increasing worldwide. This phenomenon is strongly associated with the appearance of a new "hypervirulent" strain in several countries. More-effective strategies are needed for the prevention and treatment of this entity. This article will review the current approaches using antimicrobials, probiotics, immunomodulation, surgery, and miscellaneous adjuvants to prevent and treat this infection.
引用
收藏
页码：S122 / S128
页数：7
相关论文
共 50 条
  • [31] Management of inflammatory bowel disease with Clostridium difficile infection
    Julie D'Aoust
    Robert Battat
    Talat Bessissow
    World Journal of Gastroenterology, 2017, 23 (27) : 4986 - 5003
  • [32] Clostridium difficile infection: management strategies for a difficult disease
    Khanna, Sahil
    Pardi, Darrell S.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2014, 7 (02) : 72 - 86
  • [33] Comparison of clinical and microbiological response to treatment of Clostridium difficile associated disease with metronidazole and vancomycin
    Al-Nassir, Wafa N.
    Sethi, Ajay K.
    Nerandzic, Michelle M.
    Bobulsky, Greg S.
    Jump, Robin L. P.
    Donskey, Curtis J.
    CLINICAL INFECTIOUS DISEASES, 2008, 47 (01) : 56 - 62
  • [34] The molecular pathogenesis of Clostridium difficile-associated disease
    David A. Bobak
    Current Infectious Disease Reports, 2008, 10 (2) : 111 - 115
  • [35] Recent advances in Clostridium difficile-associated disease
    Monaghan, T.
    Boswell, T.
    Mahida, Y. R.
    POSTGRADUATE MEDICAL JOURNAL, 2009, 85 (1001) : 152 - 162
  • [36] The comparative pathology of Clostridium difficile-associated disease
    Keel, M. K.
    Songer, J. G.
    VETERINARY PATHOLOGY, 2006, 43 (03) : 225 - 240
  • [37] Clostridium difficile-associated disease - an increasing burden
    Poxton, I. R.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2006, 36 (03): : 216 - 219
  • [38] CIPROFLOXACIN-ASSOCIATED CLOSTRIDIUM-DIFFICILE DISEASE
    MCFARLAND, LV
    BAUWENS, JE
    MELCHER, SA
    SURAWICZ, CM
    GREENBERG, RN
    ELMER, GW
    LANCET, 1995, 346 (8980): : 977 - 978
  • [39] Recommendations for surveillance of Clostridium difficile-associated disease
    McDonald, L. Clifford
    Coignard, Bruno
    Dubberke, Erik
    Song, Xiaoyan
    Horan, Teresa
    Kutty, Preeta K.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (02): : 140 - 145
  • [40] New agents for Clostridium difficile-associated disease
    Guiles, Joseph
    Critchley, Ian
    Sun, Xicheng
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (11) : 1671 - 1683
12345